Clin2
NCT07865572Possibly a fitNot yet recruiting

Clot removal with or without clot-dissolving medicine for pulmonary embolism

Acute Pulmonary Embolism

This trial tests two ways to treat a serious blood clot in the lungs: removing the clot with a small tube (catheter) alone, or combining that with a low dose of clot-dissolving medicine. The goal is to find a safer and effective treatment for people who can't have standard clot-busting treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old
  • You have been diagnosed with a pulmonary embolism within the last 14 days
  • You have signs of heart strain from the clot, like an enlarged right heart or high troponin levels
  • You have a reason why you can't have standard clot-busting medicine, or it didn't work, or you got worse while on blood thinners
  • The clot is visible in the main or large lung arteries on a CT scan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07032025Not yet recruiting· Early Phase 1
Clot removal procedure for acute pulmonary embolism

This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.

NCT07869875Not yet recruiting
Comparing three catheter treatments for acute pulmonary embolism

This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.

NCT07681154Not yet recruiting
Catheter treatment for moderate-risk blood clots in the lungs

This study tests a new catheter-based device that delivers clot-dissolving medicine directly to the blood clot in the lungs for people with a moderate-risk pulmonary embolism. The goal is to improve blood flow to the lungs and relieve symptoms with a lower dose of medication than standard care.

NCT06487052Recruiting
Catheter-based clot-dissolving drug for intermediate-high risk pulmonary embolism

This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.

Saint Petersburg
NCT06833827Recruiting
Clot removal vs clot-busting drugs for severe lung clots

This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.

Leiden, South Holland
NCT07003646Recruiting
Treating acute pulmonary embolism with clot-dissolving or catheter procedures

This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.

Aarhus

Hear when a new Acute Pulmonary Embolism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.